Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α- dependent host resistance to the intracellular pathogen, Toxoplasma gondii

Journal of Experimental Medicine

Volumn 189, Issue 7, 1999, Pages 1083-1091

  Yap, George S ^a   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cell mediated immunity; Inducible nitric oxide synthase; Interferon ; Toxoplasma; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL COMPARTMENTALIZATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; ENZYME INDUCTION; HEMATOPOIETIC CELL; HOST PARASITE INTERACTION; HOST RESISTANCE; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII;

ACUTE DISEASE; ANIMALS; ASTROCYTES; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CELLS; CHRONIC DISEASE; EPITHELIAL CELLS; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INTERFERON TYPE II; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MACROPHAGES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RADIATION CHIMERA; RECEPTORS, INTERFERON; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033526013     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.7.1083     Document Type: Article

References (50)

1. Biron, C.A., and R.T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infection: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485-496.
2. Schluter, D., N. Kaefer, H. Hof, O. Wiestler, and M.D. Schluter. 1997. Expression pattern and cellular origin of cytokines in normal and Toxoplasma gondii infected brain. Am. J. Pathol. 150:1021-1035.
3. + T lymphocyte plasma membrane. J. Exp. Med. 174: 755-759.
4. Unanue, E.R. 1997. Why listeriosis? A perspective on cellular immunity to infection. Immunol. Rev. 158:5-9.
5. Reiner, S.L., and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151-177.
6. Kaufmann, S.H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
7. Nathan, C., and Q. Xie. 1994. Nitric oxide synthases: roles, tolls and controls. Cell. 78:915-918.
8. Gazzinelli, R.T., E.Y. Denkers, and A. Sher. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity to intracellular parasites. Infect. Agents Dis. 2:139-149.
9. Remington, J.S., J.L. Krahenbuhl, and J.W. Mendenhall. 1972. A role for activated macrophages in resistance to infection with Toxoplasma. Infect. Immun. 6:829-834.
10. Remington, J.S., and T.C. Merigan. 1968. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science. 161:804-806.
11. Chinchilla, M., and J.K. Frenkel. 1978. Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells. Infect. Immun. 19:999-1012.
12. Pfefferkorn, E. 1984. Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc. Natl. Acad. Sci. USA. 81:908-912.
13. Shirahata, T., and K. Shimizu. 1982. Growth inhibition of Toxoplasma gondii in cell cultures treated with murine type II interferon. Jpn. J. Vet. Sci. 44:865-871.
14. Staeheli, P. 1990. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38:147-200.
15. Werk, R. 1985. How does Toxoplasma gondii enter host cells? Rev. Infect. Dis. 7:449-457.
16. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175-180.
17. Hunter, C.A., E. Candolfi, C. Subauste, V. Van Cleave, and J.S. Remington. 1995. Studies on the role of IL-12 in acute murine toxoplasmosis. Immunology. 84:16-20.
18. Denkers, E.Y., G. Yap, T. Scharton-Kersten, H. Charest, B.A. Butcher, P. Caspar, S. Hieny, and A. Sher. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159:1903-1908.
19. + immune T cells against toxoplasmosis in mice. J. Immunol. 144:1954-1956.
20. Suzuki, Y., F.K. Conley, and J.S. Remington. 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045-2050.
21. Gazzinelli, R.T., I.A. Eltoum, T. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
22. Scharton-Kersten, T.M., T.A. Wynn, E.Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R.T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045-4054.
23. Deckert-Schluter, M., H. Bluethmann, A. Rang, H. Hof, and D. Schluter. 1998. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol. 160:3427-3436.
24. Yap, G.S., T. Scharton-Kersten, H. Charest, and A. Sher. 1998. Decreased resistance of TNF receptor p55 and p75 deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1340-1345.
25. Khan, I.A., T. Matsuura, and L.H. Kasper. 1998. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J. Immunol. 161: 2994-3000.
26. Scharton-Kersten, T.M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
27. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon γ receptor. Science. 259:1742-1745.
28. Erickson, S.L., F.J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K.C. Sheehan, R.D. Schreiber, D.V. Goeddel, and M.W. Moore. 1994. Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 372:560-563.
29. Rothe, J., W. Lesslauer, H. Loetscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection with Listeria monocytogenes. Nature. 364:798-802.
30. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650.
31. Swihart, K., U. Fruth, N. Messmer, K. Hug, R. Behin, S. Huang, G. Del Giudice, M. Aguet, and J. Louis. 1995. Mice from a genetically resistant background lacking the interferon γ receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4 T cell response. J. Exp. Med. 181:961-971.
32. Ma, X., G. Chow, G. Gri, F. Carra, F. Gerosa, S. Wolf, R. Dzialo, and G. Trichieri. 1996. The interleukin 12 p40 gene promoter is primed by IFN-γ in monocytic cells. J. Exp. Med. 183:147-157.
33. Flesch, I.E., J.H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S.H.E. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 181:1615-1621.
34. Endres, R., A. Luz, H. Schulze, H. Neubauer, A. Futterer, S.M. Holland, H. Wagner, and K. Pfeffer. 1997. Listeriosis in p47 (phox -/-) and TNF R p55 -/-mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity. 7:419-432.
35. Bach, E.A., M. Aguet, and R.D. Schreiber. 1997. The IFNγ receptor: a paradigm for cytokine receptor signalling. Annu. Rev. Immunol. 15:563-591.
36. Boehm, U., T. Klamp, M. Groot, and J.C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
37. Chao, C.C., W.R. Anderson, S. Hu, G. Gekker, A. Martella, and P.K. Peterson. 1993. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67:178-183.
38. Adams, L.B., J.B. Hibbs, R.R. Taintor, and J.L. Krahenbuhl. 1990. Microbiostatic effect of murine activated macrophages for Toxoplasma gondii: role for inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725-2729.
39. Halonen, S.K., F.C. Chiu, and L.M. Weiss. 1998. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect. Immun. 66:4989-4993.
40. Nagineni, C.N., K. Pardhasaradhi, M. Martins, B. Detrick, and J.J. Hooks. 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:4188-4196.
41. Daubener, W., C. Remscheid, S. Nockemann, K. Pilz, S. Seghrouchni, C. Mackenzie, and U. Hadding. 1996. Antiparasitic effector mechanisms in human brain tumor cells: role of interferon-γ and tumor necrosis factor-α Eur. J. Immunol. 26:487-492.
42. Thomas, S.R., D. Mohr, and R. Stocker. 1994. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-γ primed mononuclear phagocytes. J. Biol. Chem. 269:14457-14464.
43. Murray, H.W., A. Szuro-Sudol, D. Wellner, M.J. Oca, A.M. Granger, D.M. Libby, C.D. Rothermel, and B.Y. Rubin. 1989. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect. Immun. 57:845-849.
44. Schwartzman, J.D., S.L. Gonias, and E.R. Pfefferkorn. 1990. Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts. Infect. Immun. 58:833-834.
45. Alberati-Giani, D., P. Malherbe, P. Ricciardi-Castagnoli, C. Kohler, D. Denis-Donini, and A.M. Cesura. 1997. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma activated murine macrophages and microglial cells. J. Immunol. 159:419-426.
46. Woodman, J.P., I.H. Dimier, and D. Bout. 1991. Human endothelial cells are activated by IFN-γ to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J. Immunol. 147:2019-2023.
47. Igietseme, J.U., L.L. Perry, G.A. Ananaba, I.M. Uriri, O.O. Ojior, S.N. Kumar, and H.D. Caldwell. 1998. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun. 66:1282-1286.
48. Gupta, S., J.M. Carlin, P. Pyati, W. Dai, E. Pfefferkorn, and M. Murphy. 1994. Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62:2277-2284.
49. Habara-Ohkubo, A., T. Shirahata, O. Takikawa, and R. Yoshida. 1993. Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3 dioxygenase. Infect. Immun. 61:1810-1813.
50. Guidotti, L., T. Ishikawa, M. Hobbs, B. Matzke, R. Schreiber, and F. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.